1. Home
  2. IMUX vs GSIT Comparison

IMUX vs GSIT Comparison

Compare IMUX & GSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • GSIT
  • Stock Information
  • Founded
  • IMUX 2016
  • GSIT 1995
  • Country
  • IMUX United States
  • GSIT United States
  • Employees
  • IMUX N/A
  • GSIT N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • GSIT Semiconductors
  • Sector
  • IMUX Health Care
  • GSIT Technology
  • Exchange
  • IMUX Nasdaq
  • GSIT Nasdaq
  • Market Cap
  • IMUX 90.4M
  • GSIT 98.7M
  • IPO Year
  • IMUX N/A
  • GSIT N/A
  • Fundamental
  • Price
  • IMUX $0.82
  • GSIT $3.39
  • Analyst Decision
  • IMUX Strong Buy
  • GSIT
  • Analyst Count
  • IMUX 5
  • GSIT 0
  • Target Price
  • IMUX $7.50
  • GSIT N/A
  • AVG Volume (30 Days)
  • IMUX 1.4M
  • GSIT 165.9K
  • Earning Date
  • IMUX 11-06-2025
  • GSIT 10-23-2025
  • Dividend Yield
  • IMUX N/A
  • GSIT N/A
  • EPS Growth
  • IMUX N/A
  • GSIT N/A
  • EPS
  • IMUX N/A
  • GSIT N/A
  • Revenue
  • IMUX N/A
  • GSIT $22,130,000.00
  • Revenue This Year
  • IMUX N/A
  • GSIT N/A
  • Revenue Next Year
  • IMUX N/A
  • GSIT N/A
  • P/E Ratio
  • IMUX N/A
  • GSIT N/A
  • Revenue Growth
  • IMUX N/A
  • GSIT 6.14
  • 52 Week Low
  • IMUX $0.56
  • GSIT $1.62
  • 52 Week High
  • IMUX $2.11
  • GSIT $5.89
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 45.68
  • GSIT 52.40
  • Support Level
  • IMUX $0.75
  • GSIT N/A
  • Resistance Level
  • IMUX $0.90
  • GSIT $3.39
  • Average True Range (ATR)
  • IMUX 0.05
  • GSIT 0.15
  • MACD
  • IMUX -0.00
  • GSIT -0.03
  • Stochastic Oscillator
  • IMUX 47.20
  • GSIT 97.70

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

Share on Social Networks: